QuickLinks -- Click here to rapidly navigate through this document

Exhibit 1.1

WH HOLDINGS (CAYMAN ISLANDS) LTD.
WH CAPITAL CORPORATION

$275,000,000 91/2% Notes due 2011

PURCHASE AGREEMENT

        March 3, 2004
New York, New York

UBS SECURITIES LLC
677 Washington Boulevard
Stamford, Connecticut 06901

Ladies and Gentlemen:

        WH Holdings (Cayman Islands) Ltd., a Cayman Islands exempted limited liability company (the "Company") and WH Capital Corporation, a Nevada corporation ("Capital," and together with the Company, the "Issuers"), agree with you as follows:

        1.    Issuance of Notes.    The Issuers propose to issue and sell to UBS Securities LLC (the "Initial Purchaser") $275,000,000 aggregate principal amount of their 91/2% Notes due 2011 (the "Original Notes"). The Original Notes will be issued pursuant to an indenture (the "Indenture"), to be dated the Closing Date (as defined herein), by and among the Issuers and The Bank of New York, as trustee (the "Trustee"). Capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Offering Memorandum (as defined herein).

        The Original Notes will be offered and sold to the Initial Purchaser pursuant to an exemption from the registration requirements under the Securities Act of 1933, as amended (the "Act"). The Issuers have prepared a preliminary offering memorandum, dated February 20, 2004 (the "Preliminary Offering Memorandum"), and a final offering memorandum dated and available for distribution on the date hereof (the "Offering Memorandum") relating to the Issuers and the Original Notes.

        The Initial Purchaser has advised the Issuers that the Initial Purchaser intends, as soon as it deems practicable after this Purchase Agreement (this "Agreement") has been executed and delivered, to resell (the "Exempt Resales") the Original Notes purchased by the Initial Purchaser under this Agreement in private sales exempt from registration under the Act on the terms set forth in the Offering Memorandum, as amended or supplemented, solely to (i) persons whom the Initial Purchaser reasonably believes to be "qualified institutional buyers," as defined in Rule 144A under the Act ("QIBs"), and (ii) other eligible purchasers pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Act; the Persons specified in clauses (i) and (ii) are sometimes collectively referred to herein as the "Eligible Purchasers."

        Upon issuance of the Original Notes and until such time as the same is no longer required under the applicable requirements of the Act, the Original Notes shall bear the legend relating thereto substantially in the form set forth under "Notice to Investors" in the Offering Memorandum.

        Holders (including subsequent transferees) of the Original Notes will have the registration rights set forth in the registration rights agreement, to be dated the Closing Date, substantially in the form attached hereto as Annex A (the "Registration Rights Agreement"). Pursuant to the Registration Rights Agreement, the Issuers will agree to (i) file with the Securities and Exchange Commission (the "Commission") under the circumstances set forth in the Registration Rights Agreement, (a) a registration statement under the Act (the "Exchange Offer Registration Statement") relating to a new issue of debt securities (collectively with the Private Exchange Notes (as defined in the Registration Rights Agreement) as the "Exchange Notes" and, the Exchange Notes are referred to herein, together with the Original Notes, as the "Notes") to be offered in exchange for the Original Notes (the "Exchange Offer") and issued under the Indenture or indentures substantially identical to the



Indenture and/or (b) under certain circumstances set forth in the Registration Rights Agreement, a shelf registration statement pursuant to Rule 415 under the Act (the "Shelf Registration Statement" and, together with the Exchange Offer Registration Statement, the "Registration Statements") relating to the resale by certain holders of the Original Notes, and (ii) to use its reasonable best efforts to cause such Registration Statements to be declared effective. This Agreement, the Notes, the Indenture and the Registration Rights Agreement are hereinafter sometimes referred to collectively as the "Note Documents."

        As described in the Offering Memorandum under the caption "The recapitalization of Holdings and related transactions," the net proceeds of the offering of the Notes, together available cash, will be used as a part of a recapitalization of the Company, pursuant to which the Company will redeem all of its outstanding 12% Series A Convertible Preferred Shares (the "Holdings Preferred Stock") and pay accrued and unpaid dividends thereon, purchase the Company's outstanding 15.5% Senior Notes due 2011 (the "Holdings Senior Notes") at a negotiated price, repay a portion of Herbalife's senior credit facilities (the "Herbalife Senior Credit Facilities"), and pay related fees and expenses.

        The issuance and sale of the Original Notes, the redemption of the Holdings Preferred Stock, the purchase of the Holdings Senior Notes and the prepayment of a portion of the Herbalife Senior Credit Facilities and the payment of related fees and expenses are referred to as the "Transactions."

        2.    Agreements to Sell and Purchase.    On the basis of the representations, warranties and covenants contained in this Agreement and subject to the terms and conditions contained in this Agreement, the Issuers agree to issue and sell to the Initial Purchaser and the Initial Purchaser agrees to purchase from the Issuers, $275,000,000 aggregate principal amount of Original Notes at a purchase price equal to 97.25% of their principal amount.

        3.    Delivery and Payment.    Delivery of, and payment of the purchase price for, the Original Notes will be made at 9:00 a.m., New York time, on March 8, 2004 (such date and time, the "Closing Date") at the offices of Gibson, Dunn & Crutcher LLP, 2029 Century Park East, Suite 4000, Los Angeles, California 90067. The Closing Date and the location of delivery of and the form of payment for the Original Notes may be varied by mutual agreement between the Initial Purchaser and the Issuers.

        All of the Original Notes will be delivered by the Issuers to the Initial Purchaser (or as the Initial Purchaser may direct) against payment by the Initial Purchaser of the purchase price therefor by means of transfer of immediately available funds to such account or accounts specified by the Issuers in accordance with its obligations under Section 4(g) hereof on or prior to the Closing Date, or by such means as the parties hereto agree prior to the Closing Date. Delivery of the Original Notes shall be made through the facilities of the Depositary Trust Company ("DTC") unless the Initial Purchaser shall otherwise instruct. The Original Notes shall be evidenced by one or more certificates in global form registered in such names as the Initial Purchaser may request upon at least one business day's notice prior to the Closing Date and having an aggregate principal amount corresponding to the aggregate principal amount of the Original Notes.

        4.    Agreements of the Issuers.    Each of the Issuers severally covenants and agrees with the Initial Purchaser as follows:

2


3


4


        5.    Representations and Warranties.    (a) Each of the Issuers hereby severally and not jointly represents and warrants to the Initial Purchaser that:

5


6


7


8


9


10


11


12


13


14


        Terms used in this Section 5(b)(ii) have the meanings given to them by Regulation S.

        The Initial Purchaser understands that the Issuers and, for purposes of the opinions to be delivered to them pursuant to Section 8 hereof, counsel to the Issuers and counsel to the Initial Purchaser will rely upon the accuracy and truth of the foregoing representations, and the Initial Purchaser hereby consents to such reliance.

        6.    Indemnification.    (a) Each of the Issuers, jointly and severally agrees to indemnify and hold harmless the Initial Purchaser, each person, if any, who controls any Initial Purchaser within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act, the agents, employees, officers and directors of any Initial Purchaser and the agents, employees, officers and directors of any such controlling person from and against any and all losses, liabilities, claims, damages and expenses whatsoever (including, but not limited, to reasonable attorneys' fees and any and all reasonable expenses whatsoever incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all reasonable amounts paid in settlement of any claim or litigation) (collectively, "Losses") to which they or any of them may become subject under the Act, the Exchange Act or otherwise insofar as such Losses (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Preliminary Offering Memorandum or the Offering Memorandum, or in any supplement thereto or amendment thereof, or arise out of or are based upon the omission or alleged omission to state therein a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the foregoing indemnity agreement shall not apply any such case to the extent, but only to the extent, that any such Loss arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission relating to the Initial Purchaser made therein in reliance upon and in conformity with written information furnished to either of the Issuers by or on behalf of the Initial Purchaser expressly for use therein; provided, however, that with respect to any untrue statement or alleged untrue statement in or omission or alleged omission from the Preliminary Offering Memorandum, the indemnity agreement contained in this section shall not inure to the benefit of the Initial Purchaser if the Initial Purchaser sold the Notes concerned to the Person asserting any such Losses, to the extent that such sale was an initial resale by the Initial Purchaser and any such Losses of the Initial Purchaser results from the fact that there was not sent or given to such Person, at or prior to the written confirmation of the sale of such Notes to such Person, a copy of the Offering Memorandum (exclusive of any material included therein but not attached thereto) if the Issuers had previously furnished copies thereof to the Initial Purchaser. This indemnity agreement will be in addition to any liability that the Issuers may otherwise have, including, but not limited to, liability under this Agreement.

15


        7.    Contribution.    In order to provide for contribution in circumstances in which the indemnification provided for in Section 6 of this Agreement is for any reason held to be unavailable

16


from an indemnifying party, or is insufficient to hold harmless a party indemnified under Section 6 of this Agreement, each party that is obligated under Section 6 of this Agreement to indemnify any other party shall contribute to the amount paid or payable by such indemnified party as a result of such aggregate Losses (i) in such proportion as is appropriate to reflect the relative benefits received by the Issuers, on the one hand, and the Initial Purchaser, on the other hand, from the offering of the Original Notes or (ii) if such allocation is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to above but also the relative fault of the Issuers on the one hand, and the Initial Purchaser, on the other hand, in connection with the statements or omissions that resulted in such Losses, as well as any other relevant equitable considerations. The relative benefits received by the Issuers and the Guarantors, on the one hand, and the Initial Purchasers, on the other hand, shall be deemed to be in the same proportion as (x) the total proceeds from the offering of Original Notes (net of discounts and commissions but before deducting expenses) received by the Issuers are to (y) the total discount, commissions and other compensation received by the Initial Purchaser. The relative fault of the Issuers, on the one hand, and the Initial Purchaser, on the other hand, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Issuers, or the Initial Purchasers and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission or alleged statement or omission.

        Each of the Issuers and the Initial Purchaser agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to above. Notwithstanding the provisions of this Section 7, (i) in no case shall the Initial Purchaser be required to contribute any amount in excess of the amount by which the total discount, commissions and other compensation applicable to the Original Notes purchased by the Initial Purchaser pursuant to this Agreement exceeds the amount of any damages that the Initial Purchaser has otherwise been required to pay by reason of any untrue or alleged untrue statement or omission or alleged omission and (ii) no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 7, each person, if any, who controls the Initial Purchaser within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act shall have the same rights to contribution as the Initial Purchaser, and each person, if any, who controls either of the Issuers within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act and each director, officer, employee and agent of each of the Issuers shall have the same rights to contribution as the Issuers. Any party entitled to contribution will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made against another party or parties under this Section 7, notify such party or parties from whom contribution may be sought, but the omission to so notify such party or parties shall not relieve the party or parties from whom contribution may be sought from any obligation it or they may have under this Section 7 or otherwise, except to the extent that it has been prejudiced in any material respect by such failure; provided, however, that no additional notice shall be required with respect to any action for which notice has been given under Section 6 of this Agreement for purposes of indemnification. Anything in this section to the contrary notwithstanding, no party shall be liable for contribution with respect to any action or claim settled without its written consent; provided, however, that such written consent was not unreasonably withheld.

        8.    Conditions to the Initial Purchaser's Obligations.    The obligations of the Initial Purchaser to purchase and pay for the Original Notes, as provided for in this Agreement, shall be subject to satisfaction of the following conditions prior to or concurrently with such purchase:

17


18


        If any of the conditions specified in this Section 8 shall not have been fulfilled when and as required by this Agreement to be fulfilled (or waived by the Initial Purchaser), this Agreement may be terminated by the Initial Purchaser on notice to the Issuers and at any time at or prior to the Closing Date, and such termination shall be without liability of any party to any other party. Notwithstanding any such termination, the provisions of Sections 4(f), 6, 7, 9, 10 and 11(d) shall remain in effect.

        The documents required to be delivered by this Section 8 will be delivered at the office of counsel for the Initial Purchaser on the Closing Date.

        9.    Initial Purchaser Information.    The Issuers and the Initial Purchaser severally acknowledge that the statements with respect to the delivery of the Original Notes to the Initial Purchaser set forth in the third, sixth, seventh, eighth, tenth and eleventh paragraph under "Plan of Distribution" in the Preliminary Offering Memorandum and the Offering Memorandum constitute the only information furnished in writing by the Initial Purchaser expressly for use in the Preliminary Offering Memorandum or the Offering Memorandum.

        10.    Survival of Representations and Agreements.    All representations and warranties, covenants and agreements contained in this Agreement, including the agreements contained in Sections 4(f) and 11(d), the indemnity agreements contained in Section 6 and the contribution agreements contained in Section 7, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Initial Purchaser or any controlling person thereof or by or on behalf of either of the Issuers or any controlling person thereof, and shall survive delivery of and payment for the Original Notes to and by the Initial Purchaser. The agreements contained in Sections 4(f), 6, 7, 9 and 11(d) shall survive the termination of this Agreement, including pursuant to Section 11.

        11.    Effective Date of Agreement; Termination.    (a) This Agreement shall become effective upon execution and delivery of a counterpart hereof by each of the parties hereto.

19


        12.    Notice.    All communications with respect to or under this Agreement, except as may be otherwise specifically provided in this Agreement, shall be in writing and, if sent to the Initial Purchaser, shall be mailed, delivered, or, telegraphed or telecopied and confirmed in writing to UBS Securities LLC, 677 Washington Boulevard, Stamford, Connecticut (telephone: (203) 719-3000, fax number: (203) 719-1075), Attention: High Yield Syndicate Department, with a copy to UBS Securities LLC, 677 Washington Boulevard, Stamford, Connecticut (telephone: (203) 719-3000, fax number: (203) 719-0680), Attention: Legal Department and to Skadden, Arps, Slate, Meagher & Flom LLP, 300 South Grand Ave., Los Angeles, California, 90071 (telephone: (213) 687-5000, fax: (213) 687-5600), Attention: Nicholas P. Saggese, Esq.; and if sent to the Issuers, shall be mailed, delivered or, telegraphed or telecopied and confirmed in writing to WH Holdings (Cayman Islands) Ltd., c/o Whitney & Co, LLC, 177 Broad Street, Stamford, Connecticut 06901 (telephone: (203) 973-4100, fax: (203) 973-1422), Attention: Mr. James Fordyce with a copy to WH Holdings (Cayman Islands) Ltd., c/o 1800 Century Park East, 15th Floor, Los Angeles, California 90067-1501 (telephone: (310) 410-9600, fax: (310) 557-3909), Attention: Brett R. Chapman, Esq. and to Gibson Dunn & Crutcher, LLP, 2029 Century Park East, Suite 4000, Los Angeles, California 90067 (telephone: (310) 552-8500, fax: (310) 551-8741), Attention: Jonathan K. Layne, Esq.

        All such notices and communications shall be deemed to have been duly given: when delivered by hand, if personally delivered; five business days after being deposited in the mail, postage prepaid, if mailed; when receipt acknowledged by telecopier machine, if telecopied; and one business day after being timely delivered to a next-day air courier.

        13.    Parties.    This Agreement shall inure solely to the benefit of, and shall be binding upon, the Initial Purchaser, the Issuers and the controlling persons and agents referred to in Sections 6 and 7 above, and their respective successors and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement

20



or any provision herein contained. The term "successors and assigns" shall not include a purchaser, in its capacity as such, of Notes from the Initial Purchaser.

        14.    Construction.    This Agreement shall be construed in accordance with the internal laws of the State of New York including, without limitation, Sections 5-1401 and 5-1402 of the New York General Obligations Law and New York Civil Practice Laws and Rules 327(b) (without giving effect to any provisions thereof relating to conflicts of law).

        15.    Captions.    The captions included in this Agreement are included solely for convenience of reference and are not to be considered a part of this Agreement.

        16.    Counterparts.    This Agreement may be executed in various counterparts that together shall constitute one and the same instrument.

21


        If the foregoing Purchase Agreement correctly sets forth the understanding among the Issuers and the Initial Purchaser, please so indicate in the space provided below for the purpose, whereupon this letter and your acceptance shall constitute a binding agreement among the Issuers and the Initial Purchaser.

        ISSUERS:

 

 

 

 

WH HOLDINGS (CAYMAN ISLANDS) LTD.

 

 

 

 

By:

 

/s/  
MICHAEL O. JOHNSON      
Name: Michael O. Johnson
Title: Chief Executive Officer

 

 

 

 

WH CAPITAL CORPORATION

 

 

 

 

By:

 

/s/  
BRETT R. CHAPMAN      
Name: Brett R. Chapman
Title: Secretary

INITIAL PURCHASER:

 

 

 

 

Confirmed and accepted as of
the date first above written:

UBS SECURITIES LLC

 

 

 

 

By:

 

/s/  
DAVID BARTH      
Name: David Barth
Title: Executive Director
           High Yield Capital Markets

 

 

 

 

By:

 

/s/  
MICHAEL F. NEWCOMB II      
Name: Michael F. Newcomb II
Title: Executive Director
           High Yield Capital Markets

 

 

 

 

Schedule I

Subsidiaries of WH Holdings (Cayman Islands) Ltd.

Subsidiary

  Type of Entity
  % Ownership
  Jurisdiction of
Incorporation

WH Capital Corporation   Corporation   100%   Nevada
WH Intermediate Holdings Ltd.   Corporation   100%   Cayman Islands
WH Luxembourg Holdings SàRL   Corporation   100% (indirect)   Luxembourg
WH Luxembourg Intermediate Holdings SàRL   Corporation   100% (indirect)   Luxembourg
WH Luxembourg CM SàRL   Corporation   100% (indirect)   Luxembourg
Herbalife International, Inc.   Corporation   100% (indirect)   Nevada
Herbalife International Argentina S.A.   Corporation   100% (indirect)   Argentina
Herbalife Australisia Pty, Ltd.   Corporation   100% (indirect)   Australia
Herbalife Foreign Sales Corporation   Corporation   100% (indirect)   Barbados
Herbalife International Belgium, S.A.   Corporation   100% (indirect)   Belgium
Herbalife International Do Brasil Ltda.   Corporation   100% (indirect)   Brazil and Delaware
Herbalife of Canada, Ltd.   Corporation   100% (indirect)   Canada
Importadora Y Distribuidora Herbalife International de Chile Limitada   Corporation   100% (indirect)   Chile
H&L (Suzhou) Health Products LTD   Corporation   100% (indirect)   Republic of China
Herbalife Denmark ApS   Corporation   100% (indirect)   Denmark
Herbalife Domincana, S.A.   Corporation   100% (indirect)   Dominican Republic
Herbalife Del Ecuador, S.A.   Corporation   100% (indirect)   Ecuador
Herbalife International Finland OY   Corporation   100% (indirect)   Finland
Herbalife International France, S.A.   Corporation   99.99% (indirect)
..01 (held by nominee)
  France
Herbalife International Deutschland GmbH   Corporation   100% (indirect)   Germany
Herbalife International Greece S.A.   Corporation   100% (indirect)   Greece
Herbalife International Hong Kong Ltd.   Corporation   100% (indirect)   Hong Kong
Herbalife Hungary Trading, Limited   Corporation   100% (indirect)   Hungary
Herbalife International India Private Limited   Corporation   85.6% (indirect)   India
PT Herbalife Indonesia   Corporation   Nominee ownership   Indonesia
Herbalife International of Israel (1990) Ltd.   Corporation   100% (indirect)   Israel
Herbalife Italia S.p.A   Corporation   100% (indirect)   Italy
Herbalife of Japan K.K.   Corporation   100% (indirect)   Japan and Delaware
Herbalife Korea Co., Ltd.   Corporation   100% (indirect)   Korea and Delaware
Herbalife International SDN.BHD   Corporation   100% (indirect)   Malaysia
Herbalife Internacional de Mexico, S.A. de C.V.   Corporation   100% (indirect)   Mexico
Herbalife Products De Mexico, S.A. de C.V.   Corporation   100% (indirect)   Mexico
Herbavida International de Mexico, S.A. de C.V.   Corporation   100% (indirect)   Mexico
Herbalife International (Netherlands) B.V.   Corporation   100% (indirect)   Netherlands
Herbalife International Products N.V.   Corporation   100% (indirect)   Netherlands Antilles
Herbalife (NZ) limited   Corporation   100% (indirect)   New Zealand
Herbalife Norway Products AS   Corporation   100% (indirect)   Norway
Herbalife International Holdings, Inc.   Corporation   40%   Philippines
Herbalife International Philippines, Inc.   Corporation   99.9% (indirect)   Philippines
Herbalife Polska Sp.z.o.o   Corporation   100% (indirect)   Poland
Herbalife International, S.A.   Corporation   100% (indirect)   Portugal
Herbalife International Russia 1995 Ltd.   Corporation   100% (indirect)   Israel
Limited Liability Company Herbalife International RS   LLC   100% (indirect)   Russia
Herbalife International Singapore, Pte. Ltd.   Corporation   100% (indirect)   Singapore
Herbalife International Espana, S.A.   Corporation   100% (indirect)   Spain
Herbalife Sweden Aktiebolag   Corporation   100% (indirect)   Sweden
HBL Products, SA   Corporation   99.7% (indirect)   Switzerland
Herbalife International Urunleri Tic. Ltd.   Corporation   100% (indirect)   Turkey and Delaware
Herbalife (UK) Limited   Corporation   100% (indirect)   United Kingdom
Herbalife Europe Limited   Corporation   100% (indirect)   United Kingdom
Vida Herbalife Suplementos Alimenticios, C.A.   Corporation   100% (indirect)   Venezuela and Delaware
             

Herbalife China LLC   LLC   100% (indirect)   Delaware
HIIP Investment Co., LLC   LLC   40%   Delaware
Herbalife International of America, Inc.   Corporation   100% (indirect)   California
Herbalife International of America, Inc.   Corporation   100% (indirect)   Nevada
Herbalife International Communications, Inc.   Corporation   100% (indirect)   California
Herbalife International Distribution, Inc.   Corporation   100% (indirect)   California
Herbalife International of Europe, Inc.   Corporation   100% (indirect)   California
Promotions One, Inc.   Corporations   100% (indirect)   California
Herbalife International del Colombia   Corporations   100% (indirect)   California
Herbalife International South Africa, Ltd.   Corporation   100% (indirect)   California
Herbalife International del Ecuador   Corporation   100% (indirect)   California
Herbalife Taiwan, Inc.   Corporation   100% (indirect)   California
Herbalife International (Thailand) Ltd.   Corporation   100% (indirect)   California

Subsidiaries of WH Capital Corporation

None.


Schedule II

Specified Subsidiaries of WH Holdings (Cayman Islands) Ltd.

Subsidiary

  Type of Entity
  % Ownership
  Jurisdiction of
Incorporation

WH Intermediate Holdings Ltd.   Corporation   100%   Cayman Islands
WH Luxembourg Holdings SàRL   Corporation   100% (indirect)   Luxembourg
WH Luxembourg Intermediate Holdings SàRL   Corporation   100% (indirect)   Luxembourg
WH Luxembourg CM SàRL   Corporation   100% (indirect)   Luxembourg
Herbalife International, Inc.   Corporation   100% (indirect)   Nevada
Herbalife Australisia Pty, Ltd.   Corporation   100% (indirect)   Australia
Herbalife International Do Brasil Ltda.   Corporation   100% (indirect)   Brazil and Delaware
Herbalife of Canada, Ltd.   Corporation   100% (indirect)   Canada
H&L (Suzhou) Health Products LTD*   Corporation   100% (indirect)   Republic of China
Herbalife International Finland OY   Corporation   100% (indirect)   Finland
Herbalife International France, S.A.   Corporation   99.99% (indirect)
..01(held by nominee)
  France
Herbalife International Deutschland GmbH   Corporation   100% (indirect)   Germany
Herbalife International Greece S.A*.   Corporation   100% (indirect)   Greece
Herbalife International Hong Kong Ltd.   Corporation   100% (indirect)   Hong Kong
Herbalife International of Israel (1990) Ltd.   Corporation   100% (indirect)   Israel
Herbalife of Japan K.K.   Corporation   100% (indirect)   Japan and Delaware
Herbalife Korea Co., Ltd.   Corporation   100% (indirect)   Korea and Delaware
Herbalife Internacional de Mexico, S.A. de C.V.   Corporation   100% (indirect)   Mexico
Herbalife Products De Mexico, S.A. de C.V.   Corporation   100% (indirect)   Mexico
Herbalife International (Netherlands) B.V.   Corporation   100% (indirect)   Netherlands
Herbalife International Singapore, Pte. Ltd.   Corporation   100% (indirect)   Singapore
Herbalife Sweden Aktiebolag   Corporation   100% (indirect)   Sweden
Herbalife International Urunleri Tic. Ltd.   Corporation   100% (indirect)   Turkey and Delaware
Herbalife (UK) Limited   Corporation   100% (indirect)   United Kingdom
Herbalife Europe Limited   Corporation   100% (indirect)   United Kingdom
Vida Herbalife Suplementos Alimenticios, C.A.   Corporation   100% (indirect)   Venezuela and Delaware
Herbalife China LLC   LLC   100% (indirect)   Delaware
Herbalife International of America, Inc.   Corporation   100% (indirect)   California
Herbalife International of America, Inc.   Corporation   100% (indirect)   Nevada
Herbalife International Communications, Inc.   Corporation   100% (indirect)   California
Herbalife International Distribution, Inc.   Corporation   100% (indirect)   California
Herbalife International of Europe, Inc.   Corporation   100% (indirect)   California
Herbalife International South Africa, Ltd.   Corporation   100% (indirect)   California
Herbalife International del Ecuador   Corporation   100% (indirect)   California
Herbalife Taiwan, Inc.   Corporation   100% (indirect)   California
Herbalife International (Thailand) Ltd.   Corporation   100% (indirect)   California

Exhibit A-1

FORM OF OPINION OF GIBSON, DUNN & CRUTCHER LLP

Ladies and Gentlemen:

        We have acted as United States special counsel to WH Holdings (Cayman Islands) Ltd., a Cayman Islands exempted limited liability company ("WH Holdings"), and as United States special counsel to WH Capital Corporation, a Nevada corporation ("WH Capital Corp." and, together with WH Holdings, the "Issuers"), in connection with the offering and sale by the Issuers of $275,000,000 in aggregate principal amount of their 91/2% Notes due 2011 (the "Initial Securities") to you pursuant to the Purchase Agreement, dated March 3, 2004 (the "Purchase Agreement"), among the Issuers and you, as initial purchaser (the "Initial Purchaser"). Terms defined in the Purchase Agreement and not otherwise defined herein are used herein as therein defined.

        In connection with the opinions herein expressed, we have reviewed the final offering memorandum, dated March 3, 2004 (the "Offering Memorandum"), relating to the offering of the Initial Securities. In addition, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following:

        The documents described under the foregoing clauses (i) through (iii), together with the Initial Securities and the Exchange Securities, are referred to herein as the "Operative Documents".

        In rendering this opinion, we have made such inquiries and examined, among other things, originals or copies, certified or otherwise identified to our satisfaction, of such records, agreements, certificates, instruments and other documents as we have considered necessary or appropriate for purposes of this opinion. As to certain factual matters, we have relied upon the representations and warranties of each Issuer in the Purchase Agreement, certificates of officers of each Issuer (copies of which are attached hereto) (collectively, the "Officers' Certificate") or certificates obtained from public officials.

        Further, we have assumed with your permission and without independent investigation that:

A-1-1


        Except as expressly stated otherwise herein, whenever an opinion herein with respect to the existence or absence of facts is stated to be to the best of our knowledge, such statement is intended to signify that, during the course of our representation of the Issuers, as herein described, no information has come to the attention of the lawyers in our Firm working on the transactions contemplated by the Offering Memorandum and the Operative Documents that would give them actual knowledge of facts contrary to the existence or absence of the facts indicated. However, we have not undertaken any independent investigation to determine the existence or absence of such facts, and no inference as to our knowledge of the existence or absence of such facts should be drawn from our representation of the Issuers or any affiliate thereof.

        Based on the foregoing and in reliance thereon, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that:

        1.     The Initial Securities, when executed by each Issuer and authenticated by the Trustee in the manner provided for in the Indenture and delivered to and paid for by the Initial Purchaser in accordance with the terms of the Purchase Agreement, will be legal, valid and binding obligations of each Issuer, enforceable against each Issuer in accordance with their terms. The Initial Securities are in the form contemplated by the Indenture.

        2.     When the Exchange Securities are executed, authenticated and delivered in the manner provided for by the terms of the Indenture, the Exchange Securities will be legal, valid and binding obligations of each Issuer, enforceable against each Issuer in accordance with their terms.

        3.     The Indenture constitutes a legal, valid and binding obligation of each Issuer, enforceable against each Issuer in accordance with its terms.

        4.     The Registration Rights Agreement constitutes a legal, valid and binding obligation of each Issuer, enforceable against each Issuer in accordance with its terms.

        5.     Insofar as the statements in the Offering Memorandum under the heading "Description of the Notes" purport to describe specific provisions of the Initial Securities, the Indenture or the Registration Rights Agreement, such statements present in all material respects an accurate summary of such provisions.

        6.     Assuming the accuracy of the representations and warranties of the Initial Purchaser and the Issuers contained in the Purchase Agreement, and compliance by them with their respective agreements contained therein, no registration of the Initial Securities under the Act is required for the purchase of the Initial Securities by the Initial Purchaser on the date hereof in the manner contemplated by the Purchase Agreement and the Offering Memorandum. The Indenture does not require qualification under the Trust Indenture Act.

        7.     The issuance of the Initial Securities, and the execution, delivery and performance by each Issuer of the Operative Documents to which it is a party, and the consummation of the Transactions, do not and will not violate, or require any filing with or approval of any governmental authority or regulatory body of the State of New York or the United States of America under, any law or regulation of the State of New York or the United States of America applicable to either of the Issuers that, in

A-1-2



our experience, is generally applicable to transactions in the nature of those contemplated by the Operative Documents, except for such filings or approvals (i) as already have been obtained or (ii) that, if not made or obtained, would not have a material adverse effect on the Issuers and their subsidiaries taken as a whole or expose the Initial Purchaser to any liability. We express no opinion in this Paragraph 7 as to the United States federal securities laws or securities or "blue sky" laws of any state, including, without limitation, the State of New York.

        8.     The execution and delivery of the Purchase Agreement, the Indenture and the Registration Rights Agreement by each Issuer and the performance by each Issuer on or prior to the date hereof of its obligations under the Purchase Agreement, the Indenture and the Registration Rights Agreement do not, as of the date hereof:

        9.     Neither of the Issuers is, or after giving effect to the offering and sale of the Initial Securities and the application of the proceeds thereof as described in the Offering Memorandum will be, required to be registered as an "investment company" within the meaning of the Investment Company Act of 1940, as amended.

        10.   To the extent that the statements in the Offering Memorandum under the caption "United States federal income tax consequences", purport to describe specific provisions of the Internal Revenue Code, such statements present in all material respects an accurate summary of such provisions.

        11.   To our knowledge, and except as set forth in the Offering Memorandum, there does not exist any judgment, order, injunction or other restraint issued or filed which seeks to restrain, enjoin, prevent the consummation of or otherwise challenges the Transactions or the performance by either of the Issuers of their respective obligations under the Operative Documents.

        12.   To our knowledge, the issuance to and resale by the Initial Purchaser of the Initial Securities in accordance with the provisions of the Purchase Agreement do not and will not result in a violation of Regulation T, U or X of the Board of Governors of the Federal Reserve System.

        The foregoing opinions are subject to the following exceptions, qualifications, assumptions and limitations:

        A.    We render no opinion herein as to matters involving the laws of any jurisdiction other than the State of New York and the United States of America. This opinion is limited to the present effect of the present state of the laws of the State of New York and the United States of America and to present judicial interpretations and to the facts as they presently exist. We assume no obligation to

A-1-3



revise or supplement this opinion in the event of any future change in such laws or any interpretation thereof or such facts.

        B.    Our opinions set forth in Paragraphs 1 through 4 are subject to (1) the effect of any bankruptcy, insolvency, reorganization, moratorium, arrangement or similar laws affecting the rights and remedies of creditors generally (including, without limitation, the effect of statutory or other laws regarding fraudulent transfers or preferential transfers or distributions by corporations to stockholders); and (2) general principles of equity, regardless of whether enforceability is considered in a proceeding in equity or at law, including without limitation concepts of materiality, reasonableness, good faith and fair dealing. We express no opinion as to the availability of specific performance, injunctive relief or other equitable remedies as a remedy for breach of or default under any of the Operative Documents.

        C.    We express no opinion as to the enforceability of provisions providing for the indemnification of or contribution to a party with respect to a liability to the extent such indemnification or contribution may be found to be contrary to public policy. We express no opinion regarding the effect on the enforceability of the Operative Documents against any surety (which could include a co-issuer of notes or co-borrower of loans jointly liable for notes or loans the proceeds of which were delivered to another co-issuer or co-borrower, a hypothecator of property to secure obligations owed by another person or a common creditor that has subordinated obligations owing to it), of any facts or circumstances that would constitute a defense to the obligation of a surety, unless such defense has been waived effectively by such surety.

        D.    We express no opinion regarding (1) the effectiveness of any waiver (whether or not stated as such) under the Operative Documents of, or any consent thereunder relating to, any unknown future rights or the rights of any party thereto existing, or duties owing to it, as a matter of law; (2) the effectiveness of any waiver (whether or not stated as such) contained in the Operative Documents of rights of any party, or duties owing to it, that is broadly or vaguely stated or does not describe the right or duty purportedly waived with reasonable specificity; or (3) provisions relating to indemnification, exculpation or contribution, to the extent such provisions may be held unenforceable as contrary to public policy or federal or state securities laws or due to the negligence or willful misconduct of the indemnified party.

        E.    In rendering our opinion expressed in Paragraph 8(ii) insofar as it requires interpretation of Material Contracts, we express no opinion with respect to the compliance by either of the Issuers with, or any financial calculations or data in respect of, financial covenants or ratios included in any Material Contract.

        F.     For purposes of our opinion in paragraph 12, we have assumed without independent investigation that: the representation and warranty of the Company set forth in Section 5(xxx) of the Purchase Agreement is and will be true and correct at all relevant times, the Issuers will comply with their agreement set forth in Section 4(g) of the Purchase Agreement, less than 25% of the value of the assets of the Issuer and its subsidiaries subject to the negative covenants of the Indenture consist and will consist of "margin stock" within the meaning of Regulations U or X of the Board of Governors of the Federal Reserve System at all relevant times. Our opinion in paragraph 12 is subject to (and we express no opinion in respect of) any requirement applicable to purchasers of the Notes to obtain in good faith a Form FR U-1 signed by the Issuers.

        We have participated in conferences with officers and other representatives of the Issuers, representatives of the independent public accountants for WH Holdings and your representatives and your counsel, at which the contents of the Offering Memorandum and related matters were discussed. Although, except as expressly stated herein, we have not verified, are not passing upon and do not assume any responsibility for the accuracy, completeness or fairness of the statements contained in the Offering Memorandum and have not made any independent verification thereof, in the course of our participation, nothing has come to our attention that caused us to believe that the Offering

A-1-4



Memorandum, as of its date, or as of the date hereof, contained or contains an untrue statement of a material fact or omitted or omits to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (it being understood that we have not been requested to, and do not make any comment with respect to, the financial statements and the notes thereto or other financial data or statistical data derived therefrom included or incorporated by reference in the Offering Memorandum).

        The opinions expressed in section II above, and the statements made in section III above, are solely for your benefit in connection with the transactions contemplated by the Operative Documents and are not to be used for any other purpose, or, circulated, quoted or otherwise referred to for any purpose, without, in each case, our written permission, except that the Trustee, in its capacity as trustee under the Indenture, may rely on this opinion as if it were addressed to it.

    Very truly yours,

A-1-5


Exhibit A-2

FORM OF OPINION OF SCHRECK BRIGNONE

Dear Ladies and Gentlemen:

        We have acted as special Nevada counsel to WH Capital Corporation, a Nevada corporation (the "Company"), in connection with the issue and sale by the Company and WH Holdings (Cayman Islands) Ltd., a Cayman Islands corporation (together with the Company, the "Issuers"), of $275,000,000 aggregate principal amount of their 91/2% Notes due 2011 (the "Original Notes"), which will be issued and sold pursuant to that certain Purchase Agreement, dated as of March 3, 2004 (the "Purchase Agreement"), by and among UBS Warburg LLC (the "Initial Purchaser") and the Issuers, and pursuant to that certain Indenture, dated as of March 8, 2004 (the "Indenture"), by and among the Issuers and The Bank of New York, as trustee (the "Trustee"). This opinion is being issued and delivered to you pursuant to Section 8(f)(ii) of the Purchase Agreement. Capitalized terms used herein, unless otherwise defined, shall have the meanings ascribed to them in the Purchase Agreement.

        For the purpose of rendering this opinion, we have examined originals, or copies certified or otherwise identified to our satisfaction as being true copies, of such records, documents, instruments and certificates as, in our judgment, are necessary or appropriate to enable us to render the opinions set forth below, including, but not limited to, the following:

        The Purchase Agreement, the Indenture, the Registration Rights Agreement and the Notes are hereinafter referred to collectively as the "Notes Documents".

        We have made such legal and factual examinations and inquiries as we have deemed necessary or appropriate for purposes of this opinion, except where a statement is qualified as to knowledge or awareness, in which case we have made no or limited inquiry as specified below. We have been furnished with, and with your consent have relied upon, as to factual matters, the Certificate and assurances of the officers and other representatives of the Company and of public officials, as we have deemed necessary for the purpose of rendering the opinions set forth herein. As to questions of fact

A-2-1



material to our opinions, we have also relied upon the statements of fact and the representations and warranties as to factual matters contained in the documents we have examined; however, except as otherwise expressly indicated, we have not been requested to conduct, nor have we undertaken, any independent investigation to verify the content or veracity thereof or to determine the accuracy of any statement, and no inference as to our knowledge of any matters should be drawn from the fact of our representation of the Company.

        Without limiting the generality of the foregoing, in rendering this opinion, we have, with your permission, assumed without independent verification that (i) the statements of fact and all representations and warranties set forth in the documents we have examined are true and correct as to factual matters; (ii) the obligations of each party set forth in such documents are its valid and binding obligations, enforceable in accordance with their respective terms; (iii) all documents that we examined accurately describe and contain the mutual understanding of the parties thereto and there are no oral or written agreements or understandings, and there is no course of prior dealing between any of the parties, that would in any manner vary or supplement the terms and provisions of such documents, or of the relationships set forth therein, or which would constitute a waiver of any of the provisions thereof by the actions or conduct of the parties or otherwise, or which would have an effect on the opinions rendered herein; (iv) each natural person executing any document has sufficient legal capacity to do so; (v) all documents submitted to us as originals are authentic, the signatures on all documents that we have examined are genuine, and all documents submitted to us as certified, conformed, photostatic or facsimile copies conform to the original document; and (vi) all corporate records made available to us by the Company and all public records we have reviewed, are accurate and complete.

        Whenever a statement herein is qualified by the phrase "to our knowledge" or "known to us" or a similar phrase, we have, with your consent, advised you concerning only the conscious awareness of facts in the possession of those attorneys who are currently members of or associated with this firm and who have performed legal services on behalf of the Company in connection with the Transactions, and which knowledge we have recognized as being pertinent to the matters set forth herein.

        As used herein, all references to (i) "Applicable Nevada Law" refers to those statutes, rules and regulations of the State of Nevada which, in our experience, are customarily applicable both to transactions of the type contemplated by the Purchase Agreement and to general business entities which are not engaged in regulated business activities; (ii) "Nevada Governmental Authorities" shall mean the governmental and regulatory authorities, bodies, instrumentalities and agencies and courts of the State of Nevada, excluding its political subdivisions and local agencies; (iii) "Nevada Governmental Order" refers to any judgment, order or decree known to us to have been issued by any Nevada Governmental Authority having jurisdiction over the Company under Applicable Nevada Law; and (iv) "Nevada Governmental Approval" refers to any consent, approval or authorization of any Nevada Governmental Authority having jurisdiction over the Company that is required to be obtained by the Company pursuant to Applicable Nevada Law.

        We are qualified to practice law in the State of Nevada. The opinions set forth herein are expressly limited to the effect on the Transactions only of the laws of the State of Nevada and we do not purport to be experts on, or to express any opinion with respect to the applicability thereto, or to the effect thereon, of, the laws of any other jurisdiction. We express no opinion herein concerning, and we assume no responsibility as to laws or judicial decisions related to, or any orders, consents or other authorizations or approvals as may be required by, any federal law, including any federal securities law, or any state securities or Blue Sky laws or regulations.

        Based upon the foregoing, and subject to the qualifications, exceptions and assumptions set forth herein, we are of the opinion that:

A-2-2


        The opinions expressed herein are based upon the Applicable Nevada Law in effect and the facts in existence as of the date of this letter. In delivering this letter to you, we assume no obligation, and we advise you that we shall make no effort, to update the opinions set forth herein, or to conduct an inquiry into the continued accuracy of such opinions, or to apprise any addressee hereof, its counsel or its assignees of any facts, matters, transactions, events or occurrences taking place, and of which we may acquire knowledge, after the date of this letter, or of any change in any Applicable Nevada Law or any facts occurring after the date of this letter, which may affect the opinions set forth herein. No opinions are offered or implied as to any matter, and no inference may be drawn, beyond the strict scope of the specific issues expressly addressed by the opinions herein.

        This opinion is rendered only to you in your capacity as the Initial Purchaser under the Purchase Agreement, and is solely for your benefit in connection with the closing of the Transactions. This opinion may not be relied upon or used by you for any other purpose, or otherwise circulated or furnished to, quoted to, or relied upon by any other person, firm or entity for any purpose, without our prior written consent in each instance except that, subject to all qualifications, limitations, exceptions and assumptions set forth herein, the Trustee may rely on this opinion letter as if it were an addressee on this date for all purposes relating to its capacity as Trustee under the Indenture.

A-2-3


Exhibit A-3

FORM OF OPINION OF SIDLEY AUSTIN BROWN & WOOD LLP

Ladies and Gentlemen:

        We address this opinion to you as the initial purchasers (the "Initial Purchasers") named in the Purchase Agreement, dated March 3, 2004 (the "Purchase Agreement"), between you and WH Holdings (Cayman Islands) Ltd., a Cayman Islands exempted limited liability company ("WH Holdings") and WH Capital Corporation, a Nevada corporation ("WH Capital" and, together with WH Holdings, the "Issuers") relating to the issuance of $275,000,000 aggregate principal amount of the Issuers' 91/2% Notes due 2011 (the "Securities"). We have acted as special regulatory counsel to the Issuers in the United States Food and Drug Administration (the "FDA") area only. In such capacity, we have been retained by the Issuers to review certain information under the captions "Risk Factors—Regulatory matters governing our industry could have a significant negative effect on our business" and "Business—Regulation—General—Products," in the Issuers' final Offering Memorandum dated March 3, 2004 (the "Offering Memorandum"). We have not been retained or engaged by the Issuers to perform, nor have we performed, any review of any other information in the Offering Memorandum, nor have we acted as the Issuers' corporate or securities counsel in connection with the issuance and sale of the Securities. Capitalized terms not defined herein shall have the meanings ascribed to them in the Purchase Agreement.

        This opinion letter is furnished to you at the request of the Issuers pursuant to Section 8(f) of the Purchase Agreement.

        In connection with the opinions expressed herein we have made such examination of matters of law and of fact as we considered appropriate or advisable for purposes hereof. We have examined such documents and such records as we have deemed appropriate, including the following:

        1.     an executed copy of the Purchase Agreement;

        2.     the Offering Memorandum; and

        3.     such other records, documents, instruments and certificates (including but not limited to certificates of public officials and officers of the Company) as we have considered necessary for purposes of this opinion.

        In rendering this opinion, we have relied without independent investigation, as to matters of fact, upon the representations and warranties of the Company in the Purchase Agreement and upon representations, both written and oral, and certificates of officers or employees of the Company, third parties and government authorities; and we have assumed the genuineness of signatures of all persons signing any documents, the authority of all persons signing any document on behalf of the parties thereto, the authority of all governmental authorities and public officials, the truth and accuracy of all matters of fact set forth in all certificates furnished to us, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies or by facsimile or other means of electronic transmission, and the authenticity of the originals of such latter documents.

        Nothing herein shall be construed to cause us to be considered "experts" within the meaning of Section 11 of the Securities Act of 1933, as amended.

        Based on and subject to the foregoing and subject to the further qualifications, exceptions and assumptions set forth below, we are of the opinion that the statements made in the Offering Memorandum under the captions "Risk Factors—Regulatory matters governing our industry could have a significant negative effect on our business" and "Business—Regulation—General—Products," insofar

A-3-1



as such statements purport to constitute a summary of the applicable provisions of the United States Federal Food, Drug and Cosmetics Act, as amended (the "FDC Act"), fairly present in all material respects such provisions.

        In acting as special regulatory counsel to the Issuers for FDA matters, during the course of preparation of the Offering Memorandum, we participated in certain discussions with certain officers and employees of the Issuers regarding the FDA regulatory matters dealt with under the captions "Risk Factors—Regulatory matters governing our industry could have a significant negative effect on our business" and "Business—Regulation—General—Products" in the Offering Memorandum. While we have not undertaken to determine independently, and we do not assume any responsibility for, the accuracy, completeness, or fairness of the statements under the above referenced captions in the Offering Memorandum, on the basis of these discussions and our activities as special regulatory counsel to the Issuers in connection with our review of the statements contained in such captioned sections, no facts have come to our attention that cause us to believe that the statements in the Offering Memorandum under such captioned sections, insofar as such statements relate to FDA regulatory matters, as of the date of the Offering Memorandum or as of the date hereof, included or includes an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading.

        The foregoing opinions and other statements are subject to the following qualifications, exceptions, assumptions and limitations:

        The foregoing opinion is limited to matters arising under the FDC Act and the regulations promulgated thereunder and we express no opinion as to any other federal laws of the United States of America or the laws, rules or regulations of any other jurisdiction or as to the municipal laws or the laws, rules or regulations or any state or local agencies or governmental authorities of or within the United States of America.

        The opinions expressed herein are given as of the date hereof, and we undertake no obligation to supplement this letter if any applicable laws change after the date hereof or of any facts or circumstances occurring or coming to our attention after the date hereof.

        This letter is solely for your benefit in connection with the transaction described in the first paragraph above and may not be quoted or relied upon by, nor may copies be made or delivered to, any other person (including, without limitation, any person who acquires the Securities from the persons to whom this is addressed), nor may this letter be relied upon by you for any other purpose without our prior written consent.

A-3-2


Exhibit A-4

FORM OF OPINION OF GENERAL COUNSEL FOR THE COMPANY

Ladies and Gentlemen:

        I am the General Counsel and Secretary of WH Holdings (Cayman Islands) Ltd., a Cayman Islands exempted limited liability company ("Holdings") and the Secretary of WH Capital Corporation, a Nevada corporation ("Capital", and together with Holdings, the "Issuers"). I have acted as legal counsel to the Issuers in connection with the offering and sale by the Issuers of $275,000,000 in aggregate principal amount of their 91/2% Notes due 2011 (the "Initial Securities") to you pursuant to the Purchase Agreement, dated March 3, 2004 (the "Purchase Agreement"), among the Issuers and you, as initial purchaser (the "Initial Purchaser"). Terms defined in the Purchase Agreement and not otherwise defined herein are used herein as therein defined.

        In connection with the opinions herein expressed, I have reviewed the final offering memorandum, dated March 3, 2004 (the "Offering Memorandum"), relating to the offering of the Initial Securities. In addition, I have examined originals, or copies certified or otherwise identified to our satisfaction, of the following:

        The documents described under the foregoing clauses (i) through (iii), together with the Initial Securities and the Exchange Securities, are referred to herein as the "Operative Documents".

        In rendering this opinion, I have made such inquiries and examined, among other things, originals or copies, certified or otherwise identified to my satisfaction, of such records, agreements, certificates, instruments and other documents and have made such other factual and legal investigations and have considered such matters of law as I deem relevant and necessary for the purposes of this opinion.

        Further, I have assumed with your permission and without independent investigation that the signatures on all documents I have examined are genuine, all individuals executing such documents had all requisite legal capacity and competency and were duly authorized, the documents submitted to me as originals are authentic and the documents submitted to me as certified or reproduction copies conform to the originals.

        With respect to any opinion herein in regard to the existence or absence of facts stated to be to my knowledge, such statement is intended to signify that I have no actual knowledge of facts contrary to the existence or absence of the facts indicated.

        Based on the foregoing and in reliance thereon, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, I am of the opinion that:

        1.     Except as set forth in the Offering Memorandum, there is: (a) no action, suit or proceeding before or by any court, arbitrator or governmental agency, body or official, domestic or foreign, now pending or, to my knowledge, threatened in writing, to which the Issuers or any of their subsidiaries is, or to my knowledge is threatened in writing to be made, a party or to which the business, assets or

A-4-1



property of the Issuers or any of their respective subsidiaries is, or to my knowledge is threatened in writing to be made, subject, (b) no statute, rule, regulation or order that has been enacted, adopted or issued, or to my knowledge, that has been proposed by any governmental body or agency, domestic or foreign, or (c) to my knowledge, no injunction, restraining order or order of any nature by a federal or state court or foreign court of competent jurisdiction to which the Issuers or any of their subsidiaries is subject that, in the case of any of clauses (a), (b) or (c), would, individually or in the aggregate, (1) have a Material Adverse Effect or (2) prevent or adversely affect the consummation of the Transactions, assuming, in the case of clause (a), such action, suit or proceeding is determined adversely to the Issuers or any of their respective subsidiaries.

        2.     None of the Issuers or any of their respective subsidiaries is (a) in violation of its charter, bylaws or other constitutive documents, (b) in default (or, with notice or lapse of time or both, would be in default) in the performance or observance of any obligation, agreement, covenant or condition contained in any of the Agreements and Instruments known to me, or (c) in violation of any law, statute, rule, regulation, judgment, order or decree of any domestic or foreign court with jurisdiction over any of them or any of their assets or properties or other governmental or regulatory authority, agency or other body, that, in the case of clauses (b) and (c) herein, individually or in the aggregate, would have a Material Adverse Effect.

        The foregoing opinions are subject to the following exceptions, qualifications, assumptions and limitations:

        A.    I am admitted to practice in the State of California and I render no opinion herein as to matters involving the laws of any jurisdiction other than the State of California. I call to your attention that each of the Operative Documents provides that it is governed by New York law and I am not providing any opinion with respect to New York law. Therefore, I have not examined the question of what law would govern the interpretation or enforcement of such Operative Documents and my opinion is based on the assumption that the internal laws of the State of California would govern the provisions of such Operative Documents and the transactions contemplated thereby. This opinion is limited to the present effect of the present state of the laws of the State of California and to present judicial interpretations and to the facts as they presently exist. I assume no obligation to revise or supplement this opinion in the event of any future change in such laws or any interpretation thereof or such facts. I express no opinion with respect to the effect or applicability of the laws of any other jurisdiction.

        B.    In rendering the opinion expressed in Paragraph 2(c), I express no opinion as to the application of any (i) local laws and regulations such as city ordinances and county zoning ordinances, that are adopted by political subdivisions below the state level, (ii) tax, insolvency, antitrust, antifraud, margin rules, trade regulation, gaming, state securities or Blue Sky laws and the Exxon Florio amendment, and (iii) laws that a lawyer exercising customary diligence would not reasonably recognize as being applicable to a transaction of this type involving these parties.

        C.    In rendering the opinion expressed in Paragraph 2(b) insofar as it requires interpretation of Agreements and Instruments, I express no opinion with respect to the compliance by either of the Issuers or any of their respective subsidiaries with, or any financial calculations or data in respect of, financial covenants or ratios included in any of the Agreements or Instruments.

        In rendering this opinion, I expressly disclaim any obligation or undertaking to update or modify this opinion as a consequence of any future changes in any laws or in the facts bearing upon this opinion.

        The opinions expressed in Section II above are solely for your benefit in connection with the transactions contemplated by the Operative Documents and are not to be used for any other purpose, or, circulated, quoted or otherwise referred to for any purpose, without, in each case, my written permission.

A-4-2


EXHIBIT A-5

FORM OF OPINION OF MAPLES & CALDER

Dear Sirs

Re:  WH Holdings (Cayman Islands) Ltd. (the "Company")

        We have acted as counsel as to Cayman Islands law to the Company in connection with its issue of US$275,000,000 91/2% Notes due 2011 (the "Notes) the proceeds of which, together with available cash, the Company will use to pay the cash redemption price due upon conversion of all of the Company's outstanding convertible preferred shares, including all accrued and unpaid dividends, to refinance a portion of the Company's existing indebtedness and to pay related fees and expenses.

1      DOCUMENTS REVIEWED

        We have reviewed originals, copies, drafts or conformed copies of the following documents:

        1.1   the Certificate of Incorporation dated 4th April, 2002 and Memorandum and Articles of Association of the Company adopted on 24th July, 2002 as amended by a special resolution passed on 11th October, 2002, an ordinary resolution to alter the share capital passed on 31st July, 2003 and special resolutions and an ordinary resolution passed on 1st March, 2004;

        1.2   the minutes of the meeting of the board of directors of the Company held on [ ], 2004 and the corporate records of the Company maintained at its registered office in the Cayman Islands;

        1.3   a Certificate of Good Standing issued by the Registrar of Companies in the Cayman Islands (the "Certificate of Good Standing");

        1.4   a certificate from a director of the Company a copy of which is annexed hereto (the "Director's Certificate"); and

        1.5   the documents listed in the Second Schedule hereto. The documents listed from 1 to 3 in the Second Schedule hereto are collectively referred to as the "Note Documents".

2      ASSUMPTIONS

        The following opinion is given only as to, and based on, circumstances and matters of fact existing and known to us on the date of this opinion. This opinion only relates to the laws of the Cayman Islands which are in force on the date of this opinion. In giving this opinion we have relied (without further verification) upon the completeness and accuracy of the Director's Certificate and the Certificate of Good Standing. We have also relied upon the following assumptions, which we have not independently verified:

        2.1   the Note Documents and the Notes have been or will be authorised and duly executed and delivered by or on behalf of all relevant parties (other than the Company as a matter of Cayman Islands law) in accordance with all relevant laws (other than the laws of the Cayman Islands);

        2.2   the Note Documents and the Notes are, or will be, legal, valid, binding and enforceable against all relevant parties in accordance with their terms under New York law and all other relevant laws (other than the laws of the Cayman Islands);

        2.3   the choice of New York law as the governing law of the Note Documents and the Notes has been made in good faith and would be regarded as a valid and binding selection which will be upheld by the courts of the State of New York as a matter of New York law and all other relevant laws (other than the laws of the Cayman Islands);

        2.4   copy documents, conformed copies or drafts of documents provided to us are true and complete copies of, or in the final forms of, the originals;



        2.5   all signatures, initials and seals are genuine;

        2.6   the power, authority and legal right of all parties under all relevant laws and regulations (other than, with respect to the Company, the laws of the Cayman Islands) to enter into, execute, deliver and perform their respective obligations under the Note Documents;

        2.7   the Notes will be issued and authenticated in accordance with the provisions of the Indenture;

        2.8   no invitation has been or will be made by or on behalf of the Company to the public in the Cayman Islands to subscribe for any of the Notes; and

        2.9   there is nothing under any law (other than the law of the Cayman Islands) which would or might affect the opinions hereinafter appearing. Specifically, we have made no independent investigation of the laws of the State of New York.

3      OPINIONS

        Based upon, and subject to, the foregoing assumptions and the qualifications set out below, and having regard to such legal considerations as we deem relevant, we are of the opinion that:

        3.1   The Company has been duly incorporated as an exempted company with limited liability and is validly existing and in good standing under the laws of the Cayman Islands.

        3.2   The Company has full power and authority under its Memorandum and Articles of Association to enter into, execute and perform its obligations under the Note Documents and the Notes including the issue and offer of the Notes pursuant to the Note Documents.

        3.3   The execution and delivery of the Note Documents and the issue and offer of the Notes by the Company and the performance of its obligations thereunder do not conflict with or result in a breach of any of the terms or provisions of the Memorandum and Articles of Association of the Company or any law, public rule or regulation applicable to the Company in the Cayman Islands currently in force.

        3.4   The execution, delivery and performance of the Note Documents has been authorised by and on behalf of the Company and, assuming the Note Documents have been executed and delivered by any Director or Officer, the Note Documents have been duly executed and delivered on behalf of the Company and constitute the legal, valid and binding obligations of the Company enforceable in accordance with their terms.

        3.5   The Notes have been duly authorised by the Company and when the Notes are signed in facsimile or manually by a Director on behalf of the Company and, if appropriate, authenticated in the manner set forth in the Indenture and delivered against due payment therefor will be duly executed, issued and delivered and will constitute the legal, valid and binding obligations of the Company enforceable in accordance with their respective terms.

        3.6   No authorisations, consents, approvals, licences, validations or exemptions are required by law from any governmental authorities or agencies or other official bodies in the Cayman Islands in connection with:


        3.7   No taxes, fees or charges (other than stamp duty) are payable (either by direct assessment or withholding) to the government or other taxing authority in the Cayman Islands under the laws of the Cayman Islands in respect of:

        The Cayman Islands currently have no form of income, corporate or capital gains tax and no estate duty, inheritance tax or gift tax.

        3.8   The courts of the Cayman Islands will observe and give effect to the choice of New York law as the governing law of the Note Documents and the Notes.

        3.9   Based solely on our inspection of the Register of Writs and Other Originating process in the Grand Court of the Cayman Islands from the date of incorporation of the Company there were no actions or petitions pending against the Company in the courts of the Cayman Islands as at close of business in the Cayman Islands on [date].

        3.10 Although there is no statutory enforcement in the Cayman Islands of judgments obtained in the State of New York, the courts of the Cayman Islands will recognise a foreign judgment as the basis for a claim at common law in the Cayman Islands provided such judgment:

        3.11 It is not necessary to ensure the legality, validity, enforceability or admissibility in evidence of the Note Documents or the Notes that any document be filed, recorded or enrolled with any governmental authority or agency or any official body in the Cayman Islands.

        3.12 The statements made in the Offering Memorandum under the heading "Cayman Islands tax consequences" are correct in so far as such statements are summaries of or relate to Cayman Islands law.

4      QUALIFICATIONS

        The opinions expressed above are subject to the following qualifications:

        4.1   The term "enforceable" as used above means that the obligations assumed by the Company under the Note Documents and the Notes are of a type which the courts of the Cayman Islands will enforce. It does not mean that those obligations will necessarily be enforced in all circumstances in accordance with their terms. In particular:


        4.2   Cayman Islands stamp duty may be payable if the original Note Documents, the agreements to transfer Notes or the original Notes (not being treated as registered Notes) are brought to or executed in the Cayman Islands.

        4.3   To maintain the Company in good standing under the laws of the Cayman Islands, annual filing fees must be paid and returns made to the Registrar of Companies.

        4.4   The obligations of the Company may be subject to restrictions pursuant to United Nations sanctions as implemented under the laws of the Cayman Islands.

        4.5   A certificate, determination, calculation or designation of any party to the Note Documents or the Notes as to any matter provided therein might be held by a Cayman Islands court not to be conclusive final and binding if, for example, it could be shown to have an unreasonable or arbitrary basis, or in the event of manifest error.

        4.6   In principle a Cayman Islands court will award costs and disbursements in litigation in accordance with the relevant contractual provisions but there remains some uncertainty as to the way in which the rules of the Grand Court will be applied in practice. Whilst it is clear that costs incurred prior to judgment can be recovered in accordance with the contract, it is likely that post-judgment costs (to the extent recoverable at all) will be subject to taxation in accordance with Grand Court Rules Order 62.

        4.7   We reserve our opinion as to the extent to which a Cayman Islands court would, in the event of any relevant illegality, sever the offending provisions and enforce the remainder of the transaction of which such provisions form a part, notwithstanding any express provisions in this regard.

        4.8   We make no comment with regard to the references to foreign statutes in the Note Documents or the Notes.

        We express no view as to the commercial terms of the Note Documents or the Notes or whether such terms represent the intentions of the parties and make no comment with respect to any representations which may be made by the Company.

        This opinion may be relied upon by the addressees only. It may not be relied upon by any other person except with our prior written consent.

Yours faithfully,


FIRST SCHEDULE

UBS Securities LLC
677 Washington Boulevard
Stamford, Connecticut 06901
USA

WH Holdings (Cayman Islands) Limited
c/o P.O. Box 309GT,
Ugland House,
South Church Street,
George Town,
Grand Cayman,
Cayman Islands


SECOND SCHEDULE

1.
Indenture dated as of [8] March, 2004 the Company, WH Capital Corporation and The Bank of New York as trustee.

2.
Purchase agreement dated as of 3 March, 2004 among the Company, WH Capital Corporation and UBS Securities LLC.

3.
Registration Rights Agreement dated as of [8] March, 2004 among the Company, WH Capital Corporation and UBS Securities LLC.

4.
Preliminary offering memorandum dated 20 February, 2004 and offering memorandum dated [3] March, 2004 (together the "Offering Memorandum").

A-5-1


Annex A

FORM OF REGISTRATION RIGHTS AGREEMENT

[attached]

Annex A-1




QuickLinks

WH HOLDINGS (CAYMAN ISLANDS) LTD. WH CAPITAL CORPORATION $275,000,000 9 1/2% Notes due 2011 PURCHASE AGREEMENT